BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28032630)

  • 1. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
    Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
    J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation.
    Hung CY; Hsieh YC; Li CH; Huang JL; Lin CH; Wu TJ
    Sci Rep; 2015 Jun; 5():11442. PubMed ID: 26094981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
    Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
    Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease.
    Singh JP; Kulik A; Levin R; Ellinor PT; Ruskin J; Avorn J; Choudhry NK
    Europace; 2012 Sep; 14(9):1287-93. PubMed ID: 22539600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of renin-angiotensin system inhibitor on left atrial remodelling in patients with chronic atrial fibrillation: long-term echocardiographic study.
    Fukuda Y; Fukuda N; Morishita S; Tamura Y
    Eur J Echocardiogr; 2011 Apr; 12(4):278-82. PubMed ID: 21266378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
    Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
    Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
    Huang CY; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
    Heart; 2018 Aug; 104(15):1276-1283. PubMed ID: 29371376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chaugai S; Meng WY; Ali Sepehry A
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibitors can suppress atrial fibrillation recurrence after encircling ipsilateral pulmonary vein isolation in patients with a non-dilated left atrium.
    Takigawa M; Yamada T; Yoshida Y; Ando M; Ishikawa K; Aoyama Y; Yamamoto T; Inoue N; Tatematsu Y; Nanasato M; Kato K; Tsuboi N; Hirayama H
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):487-95. PubMed ID: 22634400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction.
    Arslan A; Ozaydin M; Aksoy F; Arslan B; Bas HA; Erdogan D; Varol E; Dogan A
    Medicina (Kaunas); 2016; 52(2):104-9. PubMed ID: 27170483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
    Ducharme A; Schiffrin EL
    Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade therapy after surgical aortic valve replacement for severe aortic stenosis: a cohort study.
    Goel SS; Aksoy O; Gupta S; Houghtaling PL; Tuzcu EM; Marwick T; Mihaljevic T; Svensson L; Blackstone EH; Griffin BP; Stewart WJ; Barzilai B; Menon V; Kapadia SR
    Ann Intern Med; 2014 Nov; 161(10):699-710. PubMed ID: 25402513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
    Turin A; Bax JJ; Doukas D; Joyce C; Lopez JJ; Mathew V; Pontone G; Shah F; Singh S; Wilber DJ; Rabbat MG
    Am J Cardiol; 2018 Sep; 122(5):780-784. PubMed ID: 30057228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation.
    Suo Y; Zhang Z; Fu H; Zhang Y; Yuan M; Wang Y; Goudis CA; Tse G; Liu T; Li G
    J Renin Angiotensin Aldosterone Syst; 2018; 19(2):1470320318782623. PubMed ID: 29956583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillation.
    Roberts JD; Dewland TA; Glidden DV; Hoffmann TJ; Arking DE; Chen LY; Psaty BM; Olgin JE; Alonso A; Heckbert SR; Marcus GM
    Am Heart J; 2016 May; 175():9-17. PubMed ID: 27179719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system blockade is associated with the long-term protection against cardiac remodeling after cardioversion in hypertensive patients with atrial fibrillation.
    Egami Y; Nishino M; Taniike M; Makino N; Kato H; Shutta R; Yamaguchi H; Tanouchi J; Yamada Y
    Tohoku J Exp Med; 2010 Jul; 221(3):251-5. PubMed ID: 20595797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
    Lau YF; Yiu KH; Siu CW; Tse HF
    J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A; Akçay S
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the renin angiotensin system blocking in the management of atrial fibrillation.
    Soran H; Ziglam H; Al-Najjar M; Younis N
    Acta Cardiol; 2008 Aug; 63(4):457-65. PubMed ID: 18795583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.